- ►shouxi.net T Atsumi, T Nishio, H Niwa, J Takeuchi, H … - Diabetes, 2005 - Am Diabetes Assoc 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase) catalyzes
the synthesis and degradation of fructose 2,6-bisphosphate (F2,6BP), which is a
powerful activator of 6-phosphofructo-1-kinase, the rate-limiting enzyme of ... Cited by 7 - Related articles - BL Direct - All 5 versions
[CITATION] Novel isoforms of rat brain fructose 2-phospho 2-kinase/fructose 2, 6-bisphosphatase are …
T Ogura, H Osawa, Y Tang, H Onuma, M Ochi, … - FEBS letters, 2003 - Elsevier Phosphodiesterase 3B (PDE3B) gene expression is generally reduced in large
adipocytes of obese, insulin-resistant mice. This reduced gene expression is
restored by peroxisome proliferator-activated receptor (PPAR) γ ligands ... Cited by 4 - Related articles - All 7 versions
- ►physiology.org C Wu, SA Khan, LJ Peng, H Li, SG Carmella, … - American Journal of Physiology- Endocrinology And …, 2006 - Am Physiological Soc Hepatic insulin resistance is one of the characteristics of type 2 diabetes and
contributes to the development of hyperglycemia. How changes in hepatic glucose
flux lead to insulin resistance is not clearly defined. We determined the ... Cited by 4 - Related articles - BL Direct - All 2 versions
- ►ub.es [PDF] J Duran, M Gómez, A Navarro-Sabate, L … - Biochemical and Biophysical Research …, 2008 - Elsevier The bifunctional enzyme 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase
(PFK-2) catalyzes the synthesis and degradation of fructose 2,6-bisphosphate
(Fru-2,6-P 2 ), a signalling molecule that controls the balance between ... Cited by 4 - Related articles - All 5 versions
- ►ub.es [PDF] J Duran, À Navarro-Sabaté, A Pujol, JC … - Biochemical and Biophysical Research …, 2007 - Elsevier Fructose 2,6-bisphosphate (Fru-2,6-P 2 ) is an important metabolite that
controls glycolytic and gluconeogenic pathways in several cell types. Its
synthesis and degradation are catalyzed by the bifunctional enzyme 6- ... Cited by 5 - Related articles - All 6 versions
… , K Tsuchihara, DO Minchenko, H Esumi, OM … - metabolism - biopolymers.org.ua 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB) mRNA in
streptozotocin-diabetic rats vary in different organs. The expression of
different splice variants of PFKFB-3 mRNA is organ specific and changes in ... Related articles - View as HTML - All 2 versions
К ПОВІДОМЛЕННЯ - biopolymers.org.ua Вста нов ле но, що експресія мРНК 6-фос фоф
рук то-2-кінази/фрук то зо-2,6-бісфос фа та зи-3
(PFKFB-3) в різних орга нах щурів з ек спе ри ... Related articles - View as HTML
C Haskell-Luevano, A Todorovic, K Gridley, N … - Endocrine research, 2004 - Informa Pharma Science The melanocortin pathway consists of endogenous agonists, antagonists,
G‐protein coupled receptors, and ancillary proteins that mediate the function
of the endogenous antagonists. The melanocortin‐4 receptor (MC4R) is ... Cited by 1 - Related articles - All 5 versions
R Kessler, K Eschrich - Molecular Brain Research, 2001 - Elsevier In human brain we were able to demonstrate sequence diversity of the ubiquitous
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2). Six
different isoforms of PFK-2/FBPase-2, two of which are identical with the ... Cited by 20 - Related articles - All 4 versions
